APOE4-APP 相互作用对脑血管结构和功能产生早期影响:对阿尔茨海默氏症疾病的影响
Lanboling Guo1, Jessica R Gaunt1, Calvin Chee Hoe Cheah1
1Neuroscience and Mental Health Program, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
Frontiers in neuroscience
|November 10, 2025
概括
阿波利波蛋白E4 (APOE4) 和粉样前体蛋白 (APP) 之间的相互作用会导致大脑的早期血管变化. 在年轻小鼠中,这些短暂的效应表明与阿尔茨海默病进展的潜在联系.
科学领域:
- 神经科学是一个神经科学.
- 遗传学 遗传学 是一个
- 血管生物学 血管生物学
背景情况:
- APOE4和APP是阿尔茨海默病 (AD) 的关键遗传风险因素.
- 以前对基因相互作用的体内研究经常使用具有蛋白质过度表达的转基因模型.
- 这项研究的目的是研究APOE4和APP的相互作用,而无需转基因并发症.
研究的目的:
- 为了检查APOE4和APP遗传因子对大脑功能的后果.
- 为了避免转基因小鼠模型中蛋白质过度表达的局限性.
主要方法:
- 产生了具有家族APP突变和人性化的APOE4.4的双突变敲入小鼠.
- 标志着这些小鼠的遗传和生理变化.
主要成果:
- 在3个月大的双重突变小鼠中观察到血管改造基因,血管结构和血脑屏障透性的显著变化.
- 这些血管变化是基因相互作用的特征,在单个突变小鼠中不存在.
- 观察到的相互作用效应是短暂的,在8个月大时消失.
结论:
- 由APOE4和APP相互作用引起的早期血管变化可能会影响阿尔茨海默病的进展.
- 强调研究APOE4和APP的协同血管效应的重要性,特别是在年轻人中.
相关概念视频
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
Alzheimer's Disease: Treatment
782
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
782


